{"id":"W2589050849","doi":"10.1182/blood.v110.11.2579.2579","title":"First Report of a Phase II Clinical Trial of Lenalidomide Oral Therapy for Peripheral T-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; University of Ottawa; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Rash; Thalidomide; Gastroenterology; Multiple myeloma; Chemotherapy regimen; Regimen; Neutropenia; Phases of clinical research; Clinical endpoint; Surgery; Chemotherapy; Oncology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002125011,0.0001803452,0.0007950711,0.0001269396,0.00008821017,0.000006730365,0.0001487979,0.0001790126,0.0001416606],"category_scores_gemma":[0.001113046,0.0001482407,0.0005095485,0.0002119202,0.0002720834,0.00003556458,0.00004804558,0.0001002011,0.000001645817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004040938,"about_ca_system_score_gemma":0.0006566936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009728027,"about_ca_topic_score_gemma":0.00006636346,"domain_scores_codex":[0.9973652,0.00007052276,0.001283564,0.0003674027,0.0005299071,0.0003833439],"domain_scores_gemma":[0.9980003,0.0004452535,0.00036971,0.0005022259,0.0004999725,0.0001825488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7169106,0.1308786,0.03555431,0.0004747213,0.001265975,0.001757079,0.001358308,0.000002416054,0.06706041,0.00009006736,0.002154293,0.04249323],"study_design_scores_gemma":[0.8138682,0.03551203,0.0007763934,0.00006342818,0.0002294977,0.00115773,0.0002370305,0.0001338222,0.1349408,0.00009391584,0.01279233,0.0001948396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941956,0.0004976162,0.0006313832,0.0002546812,0.0001652955,0.002366757,0.0000261784,0.00002453399,0.001837977],"genre_scores_gemma":[0.9949319,0.0001927862,0.002661719,0.0001057866,0.0003890369,0.00006140217,0.00004580429,0.00004080063,0.001570728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09695753,"threshold_uncertainty_score":0.604508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08000429015003754,"score_gpt":0.4267506636782165,"score_spread":0.3467463735281789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}